Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes
A Nazha; K Al-Issa; B K Hamilton; T Radivoyevitch; A T Gerds; S Mukherjee; V Adema; A Zarzour; N Abuhadra; B J Patel; C M Hirsch; A Advani; B Przychodzen; H E Carraway; J P Maciejewski; M A Sekeres
Author Information: Leukemia Program, Department of Hematology and Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA and
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.